AIXC

AIXC is not an operating business you can underwrite — it's a shell in transition. Having divested its prior diagnostics business, it re-branded as an AI-blockchain 'crypto treasury' story (BesTrade DeAI agent, RWA + EAI). Management states plainly that these 'initiatives remain in development phases and have not generated material revenue.' The only revenue figure in the data is a stale FY2022 mark of $4.98M; FY2023, FY2024 and FY2025 revenue are simply blank. So the headline P/S of 4.5x is meaningless — it divides today's market cap by a revenue line the current business no longer produces. Underneath sits a $140M accumulated deficit, a FY2025 net loss of $17.0M, operating margin of -264.9%, and -$6.95M of operating cash flow. This is a company that consumes capital, not one that compounds it.

The one genuine positive is the balance sheet, and it exists only because of a September 2025 rescue: the $40.7M Faraday-led raise of common and Series B preferred stock. That lifted cash 1,546% to $19.3M and equity 943% to $28.0M, leaving liabilities/equity at a clean 0.15x. But that cash is earmarked to fund a speculative crypto-treasury build-out and is already being spent — and the financing came at a brutal cost to holders. Shares outstanding rose 1,137% year over year, and the MD&A discloses that after year-end, 33,858 Series B preferred shares converted into 15,074,611 new common shares at $2.246, increasing the common count by roughly 192%. The 20.2M share count and $22.3M market cap in the data are therefore pre-conversion and understate the real dilution; the -$8.11 diluted EPS is against an already-inflated base.